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The substrate peptide bond cleaved by cathepsins B and L is determined not by the amino acid contributing the carboxyl 
group to this bond as in the case of serine proteases but rather by the presence of a neighboring amino acid with a large 
hydrophobic side chain. From a study of the inhibitory potency in a series, Cbz-Phe-X-CHN,, in which Phe promotes 
binding at S, (terminology of [(1968) Biochem. Biophys. Res. Commun. 32, 898-9021) while the amino acid X probes 
S,, it is shown that this region of cathepsin L also has the ability to accommodate large hydrophobic side chains. In 
this respect cathepsin L differs from cathepsin B. Thus Cbz-Phe-Tyr(O-l-Bu)CHN, inactivates cathepsin L with a rate 
2.5 x IO4 greater than that for cathepsin B. 
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1. INTRODUCTION 
The protease, cathepsin L, initially isolated from 
rat liver lysosomes [2] is typically a 2-chain pro- 
tease in its mature form [3]. It appears to be the 
most active of the lysosomal cysteine proteases, 
which include cathepsin B, H and possibly others 
[4]. The role of cathepsin L is probably not limited 
to lysosomal protein degradation since precursor 
forms are secreted by fibroblasts upon transforma- 
tion [5,6] and by stimulated inflammatory 
macrophages [7]. Since cathepsin B has also been 
found as incompletely processed forms [8,9], in- 
terest in improved methods for the biochemical 
study of these proteases has increased. Cathepsin L 
cleaves proteins near hydrophobic amino acid 
residues which bind to subsites SZ and Sj [lO,ll], 
a specificity similar to cathepsin B [4] and attempts 
to devise selective substrates based on these pro- 
perties have not yet met with success [I 11. 
discriminating between cathepsin B and L in vitro 
and also in blocking their action in vivo. Thus, 
Cbz-Phe-AlaCHNz readily inactivates both pro- 
teases [12-141 but Cbz-Phe-PheCHNt is more ef- 
fective against cathepsin L [14]. It is evident that a 
phenylalanine residue in PZ promotes binding to 
both proteases, but that a difference exists in Si 
with respect o the size of side chain that can be ac- 
commodated. This region of cathepsin B was ex- 
plored earlier in a series of the general structure, 
Cbz-Phe-XCHN2, in which the amino acid, X, had 
side chains of differing bulk [15] to provide 
probes. Differences in reactivity up to lo4 were 
found due to steric limitations in the active center 
of cathepsin B. These inhibitors have now been ex- 
amined with cathepsin L in the hope of obtaining 
similar information and perhaps finding useful dif- 
ferences in reactivity of the two proteases. 
Synthetic inhibitors have been more useful in 2. MATERIALS AND METHODS 
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Cathepsin L was isolated from rat liver [2] and stored as the 
mercury salt [4]. The stock enzyme was 54pM by titration; 
1 : 100 dilutions, activated with thiol-containing buffer [4] at 
25°C for about 10 min, were used to prepare reaction mixtures 
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with [E] = 1.1 nM and inhibitor at 25°C. Timed aliquots were 
removed for the assay in a recording spectrofluorimeter at 37°C 
using Cbz-Phe-Arg aminomethylcoumarinylamide [4], 4 x 
lo-’ M, in the same buffer. 
The peptidyl diazomethyl ketones have been described [15] 
except for Cbz-Phe-Tyr(O-t-Bu)CHNl, m.p. 137-138”C, ob- 
tained in the usual way [15]. Prior to use, millimolar stock solu- 
tions in acetonitrile were prepared and diluted with buffer to 
provide working solutions such that the final organic solvent 
was 1 Vo (v/v) or less. Dilutions of inhibitor were favored that 
gave relatively slow inactivations to avoid saturation effects and 
to permit the assay of 4-10 aliquots. With extremely effective 
inhibitors, i.e., causing inactivations in the nanomolar range, 
this was barely possible since [I] was approaching [El. 
However, in the studies reported here, the loss of enzymatic ac- 
tivity followed lst-order kinetics as seen previously, for exam- 
ple, in the inactivation of cathepsin B by Cbz-Phe-PheCHNz 
[W. 
3. RESULTS AND DISCUSSION 
The inhibitors of this group were in general 
more effective in inactivating cathepsin L than B. 
The rates of the more active ones (table 1) are 
about lOO-fold greater for cathepsin L than for B 
[15], although the range of values is narrower for 
L. This reflects restricted binding of large substi- 
tuents in the Si region of the active center of 
cathepsin B [ 151 whereas L can accommodate such 
substituents readily. It is evident that some of the 
poorer inactivators for cathepsin B are very effec- 
tive against cathepsin L and thus may be useful for 
discriminating between these proteases. A selection 
of the more specific inhibitors of cathepsin L is 
given in table 2 for a comparison of the rates of in- 
activation. Differences of lo4 are evident as in the 
Table 1 
The effect of amino acid, X, in the reagent Cbz-Phe-X-CHNz, 
on the inactivation of cathepsin L, pH 5.4, 25°C 
X 111 
(M) 
t1/2 
(min) 
k am Inactivation 
(min-‘) rate 
(M-’ .min-‘) 
Citrulline 1.5 x 10-9 4.1 0.169 0.113 x 109 
Ser(-OBzl) 5 x lO-9 2.3 0.301 0.060 x 109 
Cys(S-Bzl) 5 x 10-9 5.9 0.117 0.0234 x lo9 
Phe(4-NOz) 5 x 10-9 11.8 0.0587 0.0117 x 109 
Tyr(O-t-Bu) 1 x 10-s 5.7 0.122 0.122 x 10s 
Tyr(O-Me) 1 x lo-* 6.5 0.107 0.107 x 108 
Trp 2 x 10-S 4.1 0.169 0.845 x 10’ 
2-Naph-Ala 2 x 10-s 5.3 0.131 0.655 x 10’ 
Thr(O-t-Bu) 2 x 1o-8 9.5 0.073 0.365 x 10’ 
homo-Phe 2 x 10-6 10.8 0.0642 0.0321 x IO6 
Table 2 
Reagents which are much more effective against cathepsin L 
than B 
Residue X in Rate of inactivation of Relative 
Cbz-Phe-X-CHNz rate 
Cathepsin L Cathepsin B 
(M-‘.min-‘) (M-‘.min-‘) 
Tyr(O-t-B@ 
Tyr(O-Me) 
Phe(4-N02) 
Trp 
1.2 x 10’ 0.62 x lo3 2.5 x lo4 
1.1 x 10’ 1.55 x 103 0.6 x lo4 
1.2 x 10’ 3 x 103 0.4 x lo4 
0.85 x 10’ 1.2 x lo4 0.7 x 103 
case of Cbz-Phe-Tyr(4-0-t-Bu)CHN2. This is con- 
siderably better than the selectivity provided by 
Cbz-Phe-PheCHNz [4]. 
The advantages of peptidyl diazomethyl ketones 
for the inactivation of the lysosomal cysteine pro- 
teases include the ability of these reagents to 
penetrate cells of diverse types and inactivate the 
proteases [16- 181. Leupeptin has sometimes been 
used for this purpose but lacks selectivity since it 
inhibits both serine and cysteine proteases [19], in 
contrast to the peptidyl diazomethyl ketones, in- 
cluding not only the lysosomal cathepsins [4] but 
also the calcium-activated proteases [20]. Possibly 
because of this, leupeptin administered to animals 
actually increases cathepsin L in various organs 
[20-221 probably by inhibiting protease degrada- 
tion. This has been ascribed to a role of the 
lysosomal cysteine proteases in their turnover [24] 
due to a similar effect of Ep-475, an epoxide inac- 
tivator of cysteine proteases [25]. On the other 
hand, a more specific inhibitor, Cbz-Phe- 
AlaCHN2 does not produce this elevated pro- 
teolytic activity in animals [23]. 
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